DJIA 17,055.87 -116.81 -0.68%
NASDAQ 4,508.69 -19.00 -0.42%
S&P 500 1,982.77 -11.52 -0.58%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Vertex Is Poised For An Earnings Breakout

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

Fed: Beware of social media, biotech stocks

Up 33%: Is Vertex Pharmaceuticals Stock Overpriced?

Read below for more on this stock, which has climbed so much year-to-date and seems to potentially be priced to perfection.

Nasdaq 100 Movers: VRTX, MYL

3 Stocks to Get on Your Watchlist

Two foreign automakers that could drive over the competition and a behemoth biotech whose valuation may deflate are this week's must-watch stocks.

Vertex Pharmaceuticals Inc Stock Upgraded (VRTX)

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Res

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Merck, Gilead Lead Race To Eradicate Hepatitis C

Time to Buy Vertex Pharmaceuticals Inc?

Vertex's cystic fibrosis franchise is just getting started.
See More Articles...